[Clinical study on naoxintong capsule for stroke recovery of Qi-deficiency and blood-stasis syndrome].
OBJECTIVE
To study the efficacy and safety of Naoxintong capsule treatment of stroke recovery with Qi-deficiency and blood-stasis syndrome (cerebral infarction), and to compared the non-inferiority analysis with the positive drug Tongxinluo capsule.


METHODS
Taking Tongxinluo capsules as control, randomized, double-blind, controlled, multi-center clinical experiments were studied. The evaluating indexes included the decrease of integral value of stroke patients, changes in traditional Chinese medicine, the improvement of the patient viability status (disability level), Chinese stroke scale (CSS), activities of daily living (DAL) scale and barthel index (BI ) points.


RESULTS
The total effect of the two groups, Chinese and other symptoms, showed no significant statistical significance.


CONCLUSIONS
Naoxintong capsule stroke recovery, with Qi-deficiency and blood-stasis syndrome (cerebral infarction) has a therapeutic effect, and more secure.
China Academy of Chinese Medial Sciences, Beijing 100700, China.
Liya
L
Su
Yingkun
Y
Li
Bin
B
Lv
Haiwang
H
Ji
Hong
H
Ding
Lingxiang
L
Hu
Suqin
S
Fang
Hui
H
Liang
Xiaoju
X
Cao
Zhong
Z
Wang
D000203:Activities of Daily Living; D000328:Adult; D000368:Aged; D002214:Capsules; D004311:Double-Blind Method; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D019413:Qi; D020521:Stroke / Q000188:drug therapy*; D016896:Treatment Outcome
D002214:Capsules; D004365:Drugs, Chinese Herbal; C571443:naoxintong; C513941:tongxinluo